Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Reproductive Cmte. Membership Reflects “Broken Process” – Crawford

Executive Summary

FDA's difficulty in staffing the Reproductive Health Drugs Advisory Committee is a result of a "broken process," Acting Commissioner Lester Crawford told a Women in Government Relations luncheon in Washington, D.C. Oct. 11
Advertisement

Related Content

IoM Drug Safety Review Will Consider Advisory Committee Process, FDA Says
IoM Drug Safety Review Will Consider Advisory Committee Process, FDA Says
FDA “Chief Messaging Officer” Pitts Will Centralize Agency Communications
FDA “Chief Messaging Officer” Pitts Will Centralize Agency Communications
FDA DTC Stance Is “Ideological,” Not Science-Based, Rep. Waxman Says
FDA Loses External Relations Head Skladany: Focus Included Staff Recruiting
FDA Reproductive Health Cmte. Line-Up Set; First Priority Will Be WHI Results
FDA Women’s Health Initiative Advisory Committee Meeting Postponed
Prempro WHI Implications For Future HRT Trials To Be Discussed By Subcmte.
Prempro WHI Implications For Future HRT Trials To Be Discussed By Subcmte.
Advertisement
UsernamePublicRestriction

Register

PS040617

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel